Compass Rose Asset Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-250,000
Closed -$1.61M 26
2025
Q3
$1.61M Sell
250,000
-250,000
-50% -$1.71M 0.27% 18
2025
Q2
$3.33M Sell
500,000
-100,000
-17% -$514K 0.67% 18
2025
Q1
$3.88M Sell
600,000
-1,500,000
-71% -$10.8M 1.21% 18
2024
Q4
$16.9M Buy
2,100,000
+1,650,000
+367% +$13.6M 6.77% 6
2024
Q3
$3.67M Buy
+450,000
New +$2.97M 3.19% 8

Other funds holding BHC

Compass Rose Asset Management's BHC Position: Q4 2025 in Review

Compass Rose Asset Management sold out of Bausch Health (BHC) in Q4 2025, closing a stake of 250,000 shares — an estimated $1.61M sold.

Compass Rose Asset Management first reported a position in BHC in Q3 2024 and held it in 5 quarters. The position peaked at $16.9M in Q4 2024. 235 funds tracked by Wall St. Rank hold BHC as of Q4 2025.

  • Compass Rose Asset Management reported no remaining Bausch Health position as of Q4 2025 after selling out during the quarter.
  • Compass Rose Asset Management sold 250,000 Bausch Health shares in Q4 2025, an estimated $1.61M.
  • Compass Rose Asset Management first reported a position in Bausch Health in Q3 2024 and held it in 5 quarters.
  • Compass Rose Asset Management's Bausch Health position peaked at $16.9M in Q4 2024.
  • 235 funds tracked by Wall St. Rank held Bausch Health as of Q4 2025.

Based on Compass Rose Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.